Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy Caucasian postmenopausal women~* BMI 30-38~Exclusion Criteria:~* Not currently weight-stable~* Diagnosed with diabetes~* Cardiovascular disease~* Endocrine disease~* Hepatic and renal disorders~* Neurological/psychological illness/history of depression~* Previous surgical procedures for weight loss~* Medications known to alter body weight or appetite~* β-blockers, fibrates and metformin~* Severe under-reporting of food intake based on a 4 day food diary

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Rimonabant treatment (20mg/d) for 12 weeks
- 2 (Type: OTHER): Dietary intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).